VC  Life Science Alternative Funding

     Office Locations:

50 Main Street, Suite 1000
White Plains, NY 10606
Phone: 914-682-2030



  • Growth



  • Medical Device



    Life Sciences Alternative Funding (LSAF) is a direct investment company focused exclusively on providing flexible financing for commercial-stage medical device and diagnostics companies. LSAF will invest $10 to $50 million over the span of 5 to 7 years. Over the last year, LSAF principals have been involved with more than $100 million of non-dilutive financings to medical device companies.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Rich Gumer CEO
    Steve DeNelsky President


    Portfolio companies include:

      Integrated Diagnostics
        web link

      VisionCare Ophthalmic Technologies
        web link


    Recent News:

      There is no recent news for Life Science Alternative Funding.